Synchronous Bilateral Large Renal Cell Carcinoma Treated With Presurgical Pembrolizumab and Lenvatinib Enabling Unilateral Partial Nephrectomy and Dialysis Avoidance: A Case Report
Pre-surgical therapy with pembrolizumab and lenvatinib effectively shrank the initially unresectable renal tumors to enable successful partial nephrectomy. This approach may be viable for patients with large bilateral renal masses.
Authors
- Satoshi Muraoka
- Hiroki Kawabata
- Takahito Wakamiya (ORCID: https://orcid.org/0000-0001-9101-1749)
- Yasuo Kohjimoto (ORCID: https://orcid.org/0000-0001-6103-6320)
- Shimpei Yamashita (ORCID: https://orcid.org/0000-0001-7402-6164)
- Yuya Iwahashi (ORCID: https://orcid.org/0000-0002-4201-1985)
- Isao Hara
Institutions
- Wakayama Medical University (JP)
Publication Details
- Journal
- IJU Case Reports
- Published
- 2025-09-15
- DOI
- https://doi.org/10.1002/iju5.70095
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Wakayama Medical University